Helicobacter is edited by Professor David Y Graham. The editorial and peer review process is an independent process. Whenever there is a conflict of interest, the editor and editorial board will declare their interests and affiliations. Helicobacter recognises the critical role that has been established for Helicobacter pylori in peptic ulcer, gastric adenocarcinoma, and primary gastric lymphoma. As new helicobacter species are now regularly being discovered, Helicobacter covers the entire range of helicobacter research, increasing communication among the fields of gastroenterology; microbiology; vaccine development; laboratory animal science.
《螺杆菌》由大卫Y Graham教授编辑。编辑和同行评审过程是一个独立的过程。每当有利益冲突时,编辑和编辑委员会将宣布他们的利益和从属关系。螺杆菌认识到幽门螺杆菌在消化性溃疡、胃腺癌和原发性胃淋巴瘤中的关键作用。随着新的螺杆菌种类的不断发现,螺杆菌涵盖了螺杆菌研究的整个范围,增加了胃肠病学领域之间的交流;微生物学;疫苗研制;实验动物科学。
Meta‐analysis of three‐in‐one single capsule bismuth‐containing quadruple therapy for the eradication of Helicobacter pylori
来源期刊:HelicobacterDOI:10.1111/hel.12570
Relative potency of proton‐pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double‐dose PPI
来源期刊:HelicobacterDOI:10.1111/hel.12554
Nationwide antibiotic resistance mapping of Helicobacter pylori in Korea: A prospective multicenter study
来源期刊:HelicobacterDOI:10.1111/hel.12592
Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing
来源期刊:HelicobacterDOI:10.1111/hel.12547
Review of antimicrobial peptides with anti‐Helicobacter pylori activity
来源期刊:HelicobacterDOI:10.1111/hel.12555
High‐dose PPI‐amoxicillin dual therapy with or without bismuth for first‐line Helicobacter pylori therapy: A randomized trial
来源期刊:HelicobacterDOI:10.1111/hel.12596
The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults
来源期刊:HelicobacterDOI:10.1111/hel.12590
Bismuth supplements as the first‐line regimen for Helicobacter pylori eradication therapy: Systemic review and meta‐analysis
来源期刊:HelicobacterDOI:10.1111/hel.12565
Helicobacter pylori infection alters gastric and tongue coating microbial communities
来源期刊:HelicobacterDOI:10.1111/hel.12567
Bismuth‐containing quadruple therapy versus concomitant quadruple therapy as first‐line treatment for Helicobacter Pylori infection in an area of high resistance to clarithromycin: A prospective, cross‐sectional, comparative, open trial
来源期刊:HelicobacterDOI:10.1111/hel.12546
Previous Helicobacter pylori infection–induced atrophic gastritis: A distinct disease entity in an understudied population without a history of eradication
来源期刊:HelicobacterDOI:10.1111/hel.12669
Review: Helicobacter pylori and extragastric diseases
来源期刊:HelicobacterDOI:10.1111/hel.12636
Systematic review: Would susceptibility‐guided treatment achieve acceptable cure rates for second‐line Helicobacter pylori therapy as currently practiced?
来源期刊:HelicobacterDOI:10.1111/hel.12584
Primary and secondary antibiotic resistance of Helicobacter pylori in Korea from 2003 to 2018
来源期刊:HelicobacterDOI:10.1111/hel.12660
Systematic review and meta‐analysis: Effect of Helicobacter pylori eradication on chronic spontaneous urticaria
来源期刊:HelicobacterDOI:10.1111/hel.12661
Cost‐effectiveness analysis of screen‐and‐treat strategy in asymptomatic Chinese for preventing Helicobacter pylori‐associated diseases
来源期刊:HelicobacterDOI:10.1111/hel.12563
Helicobacter pylori infection and prevalence of stroke
来源期刊:HelicobacterDOI:10.1111/hel.12553
Efficacy of tailored therapy for Helicobacter pylori eradication based on clarithromycin resistance and survey of previous antibiotic exposure: A single‐center prospective pilot study
来源期刊:HelicobacterDOI:10.1111/hel.12585
Gastric cancer prevention targeted on risk assessment: Gastritis OLGA staging
来源期刊:HelicobacterDOI:10.1111/hel.12571
A lucid review of Helicobacter pylori‐induced DNA damage in gastric cancer
来源期刊:HelicobacterDOI:10.1111/hel.12631
Helicobacter pylori eradication regimens in an antibiotic high‐resistance European area: A cost‐effectiveness analysis
来源期刊:HelicobacterDOI:10.1111/hel.12666
Bismuth, rabeprazole, amoxicillin, and doxycycline as first‐line Helicobacter pylori therapy in clinical practice: A pilot study
来源期刊:HelicobacterDOI:10.1111/hel.12594
Half‐dose clarithromycin‐containing bismuth quadruple therapy is effective and economical in treating Helicobacter pylori infection: A single‐center, open‐label, randomized trial
来源期刊:HelicobacterDOI:10.1111/hel.12566
Evolution of Helicobacter pylori associated with gastroduodenal ulcers or erosions in children over the past 23 years: Decline or steady state?
来源期刊:HelicobacterDOI:10.1111/hel.12629
Effectiveness and safety of furazolidone‐containing quadruple regimens in patients with Helicobacter pylori infection in real‐world practice
来源期刊:HelicobacterDOI:10.1111/hel.12591
Prevalence of Helicobacter pylori infection among junior high school students in Grudziadz, Poland
来源期刊:HelicobacterDOI:10.1111/hel.12552
The relationship of gastric microbiota and Helicobacter pylori infection in pediatrics population
来源期刊:HelicobacterDOI:10.1111/hel.12676
Once‐daily rabeprazole, levofloxacin, clarithromycin‐MR, and bismuth for Helicobacter pylori eradication: A randomized study of 7 or 14 days (ONCE study)
来源期刊:HelicobacterDOI:10.1111/hel.12615
The risk of Helicobacter pylori infection for adverse pregnancy outcomes: A systematic review and meta‐analysis
来源期刊:HelicobacterDOI:10.1111/hel.12562
Personalized therapy for Helicobacter pylori: CYP2C19 genotype effect on first-line triple therapy.
来源期刊:HelicobacterDOI:10.1111/HEL.12574
Interleukin‐27 is abrogated in gastric cancer, but highly expressed in other Helicobacter pylori‐associated gastroduodenal diseases
来源期刊:HelicobacterDOI:10.1111/hel.12667
Management of Helicobacter pylori infection by clinicians: A nationwide survey in a developing country
来源期刊:HelicobacterDOI:10.1111/hel.12656
Saccharomyces boulardii as an adjuvant therapy for Helicobacter pylori eradication: A systematic review and meta‐analysis with trial sequential analysis
来源期刊:HelicobacterDOI:10.1111/hel.12651
Mucoid and coccoid Helicobacter pylori with fast growth and antibiotic resistance
来源期刊:HelicobacterDOI:10.1111/hel.12678
High‐risk symptoms do not predict gastric cancer precursors
来源期刊:HelicobacterDOI:10.1111/hel.12548
Increasing antimicrobial resistance to clarithromycin and metronidazole in pediatric Helicobacter pylori infection in southern Taiwan: A comparison between two decades
来源期刊:HelicobacterDOI:10.1111/hel.12633
The prevalence of histologic atrophy and intestinal metaplasia in the corpus has decreased over 15 years in females in the Korean population
来源期刊:HelicobacterDOI:10.1111/hel.12579
Spasmolytic polypeptide‐expressing metaplasia associated with higher expressions of miR‐21, 155, and 223 can be regressed by Helicobacter pylori eradication in the gastric cancer familial relatives
来源期刊:HelicobacterDOI:10.1111/hel.12578
Extragastric diseases correlated with Helicobacter pylori
来源期刊:HelicobacterDOI:10.1111/hel.12549
Helicobacter pylori heteroresistance to clarithromycin in adults—New data by in situ detection and improved concept
来源期刊:HelicobacterDOI:10.1111/hel.12670
The most influential articles in Helicobacter pylori research: A bibliometric analysis
来源期刊:HelicobacterDOI:10.1111/hel.12589
The clinical meaning of the “indefinite for atrophy” lesions within gastric mucosa biopsy specimens in a region with a high prevalence of gastric cancer
来源期刊:HelicobacterDOI:10.1111/hel.12605
Combined effect between WT1 methylation and Helicobacter pylori infection, smoking, and alcohol consumption on the risk of gastric cancer
来源期刊:HelicobacterDOI:10.1111/hel.12650
Helicobacter pylori antimicrobial resistance and antibiotic consumption in the low‐resource Central America setting
来源期刊:HelicobacterDOI:10.1111/hel.12595
Gastric juice‐based PCR assay: An alternative testing method to aid in the management of previously treated Helicobacter pylori infection
来源期刊:HelicobacterDOI:10.1111/hel.12568
Molecular epidemiologic and clinical analysis of Helicobacter cinaedi bacteremia in Japan
来源期刊:HelicobacterDOI:10.1111/hel.12675
Twice‐a‐day PPI, tetracycline, metronidazole quadruple therapy with Pylera® or Lactobacillus reuteri for treatment naïve or for retreatment of Helicobacter pylori. Two randomized pilot studies
来源期刊:HelicobacterDOI:10.1111/hel.12659
Detection of Helicobacter pylori with clarithromycin resistance‐associated mutations using peptide nucleic acid probe‐based melting point analysis
来源期刊:HelicobacterDOI:10.1111/hel.12634
Low‐level primary clarithromycin resistance of Helicobacter pylori in Burkina Faso: A prospective molecular study
来源期刊:HelicobacterDOI:10.1111/hel.12551
CHAC1 overexpression in human gastric parietal cells with Helicobacter pylori infection in the secretory canaliculi
来源期刊:HelicobacterDOI:10.1111/hel.12598